A2 Biotherapeutics, Inc. | $80,000,000 | (Jan 10, 2025)
Holly | $2,200,000 | (Jan 10, 2025)
RLTYco | $20,000,000 | (Jan 10, 2025)
Certified by Founder
Lodge
Tuza (formerly Statement)
start up
United Kingdom
- London, London
- 03/05/2024
- Seed
- $5,020,220
At Tuza we're building an exchange for card payments to give businesses access to the most competitive rates for their payment terminals, while helping banks to access volume they want to process. This is important. Just like insurance, payments is a product priced on risk. But currently that risk is priced manually in spreadsheets, leading to businesses paying billions in extra card processing fees.
We're working with the largest banks in payments to fix that, bringing the biggest change to how businesses access card payments in two decades.
- Industry Financial Services
- Website https://www.tuza.co.uk/
- LinkedIn https://www.linkedin.com/company/trytuza/
Air | $35,000,000 | (Jan 10, 2025)
Prudentia Sciences | $7,000,000 | (Jan 10, 2025)
Biosphere | $8,800,000 | (Jan 10, 2025)
RyboDyn Inc. | $4,000,000 | (Jan 10, 2025)
RheumaGen | $15,000,000 | (Jan 10, 2025)
Light Horse Therapeutics | $62,000,000 | (Jan 10, 2025)
Abstract(US) | $4,800,000 | (Jan 10, 2025)
PrettyDamnQuick | $25,000,000 | (Jan 10, 2025)
Oxford Cancer Analytics | $11,000,000 | (Jan 10, 2025)
